1. Poster 155 Dysport®, AbobotulinumtoxinA, is Effective with a Favorable Safety Profile in the Treatment of Cervical Dystonia: A Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study. Issue 9 (29th September 2014) Authors: Picaut, Philippe; Poewe, Werner; Bihari, Katalin; Banach, Marta; Bares, Martin; Potulska‐Chromik, Anna; Ehler, Edvard; Liu, Wenzhong J. Journal: PM&R Issue: Volume 6:Issue 9(2014)Supplement Page Start: S238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Poster 156 Dysport®, AbobotulinumtoxinA, Improves Disease‐Specific Quality of Life in Patients with Cervical Dystonia, as Measured by Patient‐Reported Outcomes, in a Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study. Issue 9 (29th September 2014) Authors: Picaut, Philippe; Poewe, Werner; Vohanka, Stanislav; Ilkowski, Jan; Dzyak, Ludmyla; Kovacs, Tibor; Belova, Anna; Liu, Wenzhong J. Journal: PM&R Issue: Volume 6:Issue 9(2014)Supplement Page Start: S239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗